Non ST Segment Elevation Acute Coronary Syndrome Clinical Trials

24 clinical trials for Non ST Segment Elevation Acute Coronary Syndrome across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients — RECRUITING
• Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation — RECRUITING · NA
• Angio-based Final Functional Effect of PCI — RECRUITING
• "Inhibición precoz de la glucoproteina IIb/IIIa en el síndrome coronario agudo sin elevación del segmento ST: ensayo aleatorizado y controlado con placebo para evaluar los efectos clínicos beneficiosos de eptifibátida precoz con carga anterior en el tratamiento de pacientes con síndrome coronario agudo sin elevación del segmento ST". (EARLY ACS). "Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment — COMPLETED · PHASE3
• Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome — COMPLETED · NA
• Pre Hospital Triage of Patients at Intermediate and High Risk for ACS — NOT_YET_RECRUITING · NA
• Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study — ACTIVE_NOT_RECRUITING · NA
• COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) — COMPLETED · PHASE2
• Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS — COMPLETED
• Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population — NOT_YET_RECRUITING · NA
• ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction — OTHER · PHASE3
• Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients — OTHER · PHASE4
• Prasugrel Or Ticagrelor De-escalation in NSTE-ACS — OTHER · PHASE3
• Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy — COMPLETED · PHASE2
• HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt — COMPLETED · NA
• Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS — OTHER · NA
• Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling — WITHDRAWN · NA
• In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? — OTHER · NA
• EKG Criteria and Identification of Acute Coronary Occlusion — OTHER
• Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI — COMPLETED · PHASE4
• Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS — TERMINATED · PHASE4
• COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS — OTHER · PHASE4
• Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS — OTHER · PHASE3
• Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome — OTHER · PHASE3

Refine this search